Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer. Cameron S, Deblois G, Hawley JR, Qamra A, et al. Oncogene 2023 Apr 5. doi: 10.1038/s41388-023-02680.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cameron S, Deblois G, Hawley JR, Qamra A, et al. Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer. Oncogene 2023 Apr 5. doi: 10.1038/s41388-023-02680.
PMID: 37020039